PBI-4050

· Liminal BioSciences Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PBI-4050, covering 2017-04-11 to 2020-11-03. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome [Phase 2, Phase 3]